Morgan Stanley (NYSE: MS) updates prospectus for Series M preferred stock
Filing Impact
Filing Sentiment
Form Type
424B3
Rhea-AI Filing Summary
Morgan Stanley filed a prospectus addendum to offer Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M using the prospectus dated April 8, 2026. The addendum replaces the prior prospectus dated November 16, 2020 and notes that Morgan Stanley & Co. LLC may sell shares in market-making transactions.
Positive
- None.
Negative
- None.
Key Figures
Registration Number: 333-293641
Prospectus date (current): April 8, 2026
Prospectus date (superseded): November 16, 2020
3 metrics
Registration Number
333-293641
Prospectus addendum cover
Prospectus date (current)
April 8, 2026
Accompanying prospectus dated April 8, 2026
Prospectus date (superseded)
November 16, 2020
Prospectus being superseded
Key Terms
Fixed-to-Floating Rate, Non-Cumulative Preferred, Prospectus Addendum, Market‑making transactions
4 terms
Fixed-to-Floating Rate financial
"SHARES FIXED-TO-FLOATING RATE NON-CUMULATIVE PREFERRED STOCK"
A fixed-to-floating rate is a type of loan or investment that starts with a fixed interest rate for a certain period, meaning the payments stay the same, then switches to a variable rate that can change over time based on market conditions. This matters because it offers the stability of fixed payments initially, but also the flexibility to benefit if interest rates drop later.
Non-Cumulative Preferred financial
"NON-CUMULATIVE PREFERRED STOCK, SERIES M"
Prospectus Addendum regulatory
"Prospectus Addendum to the Prospectus dated April 8, 2026"
Market‑making transactions market
"will, and other affiliates of Morgan Stanley may, use this prospectus addendum in connection with offers and sales of the shares in market-making transactions"
FAQ
What does Morgan Stanley's prospectus addendum for Series M (MS) state?
The addendum updates the offering terms for Series M preferred stock and references the prospectus dated April 8, 2026. It supersedes the prior prospectus dated November 16, 2020 and permits market‑making sales by Morgan Stanley & Co. LLC.
Will Morgan Stanley receive proceeds from these Series M sales (MS)?
The addendum states Morgan Stanley & Co. LLC will and other affiliates may use the addendum for market‑making transactions. It does not state proceeds treatment or pricing in the excerpt; specific proceeds terms are in the accompanying prospectus supplement.
What are the key features named for the offered security in the MS addendum?
The security is described as Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M. The excerpt highlights that the shares are not bank deposits and are not FDIC‑insured; specific rate and terms are in the prospectus supplement.
Does the addendum change the effective prospectus date for the offering (MS)?
Yes. The addendum instructs readers to refer to the prospectus dated April 8, 2026, which supersedes the prospectus dated November 16, 2020. The prospectus supplement provides the specific offering terms.
